REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-12-15: Form 6-K; Period of report 2021-12-15; Description 6-K; Document zk2126966.htm.
- 2021-12-09: Form 6-K; Period of report 2021-12-09; Description 6-K; Document zk2126945.htm.
- 2021-12-06: Form 6-K; Period of report 2021-12-06; Description 6-K; Document zk2126930.htm.
- 2021-12-02: Form 6-K; Period of report 2021-12-02; Description 6-K; Document zk2126911.htm.